Therapeutic amniocentesis for treatment of twin-twin transfusion syndrome

被引：3

作者：

Has R. ^{[1
]}

Akhan S. ^{[1
]}

Topuz S. ^{[1
]}

Ermiş H. ^{[1
]}

Iyibozkurt C. ^{[1
]}

Ibrahimoǧlu L. ^{[1
]}

机构：

[1] Dept. of Obstetrics and Gynecology, Faculty of Medicine, University of Istanbul, 34750 Istabul

来源：

Archives of Gynecology and Obstetrics | 2005年 / 271卷 / 1期

关键词：

Therapeutic amniocentesis; Twin-twin transfusion syndrome;

D O I：

10.1007/s00404-004-0650-x

中图分类号：

学科分类号：

摘要：

Objective: The objective was to determine whether therapeutic amniocentesis may improve outcomes in patients with twin-twin transfusion syndrome. Study design: Eleven patients were managed aggressively with repetitive serial amniocenteses, and six patients were managed conservatively. Results: The time interval between diagnosis and delivery was 17.4 days more in the amniodrainage group, but the difference between the groups was not significant (68.3±41.9 days in the therapeutic amniocentesis group and 50.83±29.7 days in the expectant management group [p=0.384]). The overall survival rate of the two groups was 38.2%, and was not significantly different between groups (40.9% in the amniocentesis group and 33.3% in the expectant management group; p=1.00). Two of nine (22.2%) infants in the amnioreduction group, and one of four (25.0%) infants in the expectantly managed group had neurological symptoms. Conclusion: Our results did not show a significant benefit of aggressive therapeutic amniocentesis. A slight improvement in perinatal outcome was observed. © Springer-Verlag 2004.

引用

页码：22 / 25

页数：3

共 15 条

[1]

Gonsoulin W., Moise K.J., Kirshon B., Et al., Outcome of twin-twin transfusion diagnosed before 28 weeks of gestation, Obstet Gynecol, 75, pp. 214-216, (1990)

[2]

Duncan K.R., Denbow M.L., Fisk N.M., The etiology and management of twin-twin transfusion syndrome, Prenat Diagn, 17, pp. 1227-1236, (1997)

[3]

Sebire N.J., D'Ercole C., Hughes K., Et al., Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome, Ultrasound Obstet Gynecol, 10, pp. 86-89, (1997)

[4]

Wittmann B.K., Farquharson D.F., Thomas W.D., Et al., The role of feticide in the management of severe twin transfusion syndrome, Am J Obstet Gynecol, 155, pp. 1022-1026, (1986)

[5]

De Lia J.E., Cruikshank D.P., Keye W.R., Fetoscopic neodymium: YAG laser occlusion of placental vessels in severe twin-twin transfusion syndrome, Obstet Gynecol, 75, (1990)

[6]

Ville Y., Hyett J., Hecker K., Et al., Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome, N Engl J Med, 332, pp. 224-227, (1995)

[7]

Elliott J.P., Urig M.A., Clewell W.H., Aggressive therapeutic amniocentesis in twin-twin transfusion syndrome, Obstet Gynecol, 77, pp. 537-540, (1991)

[8]

Reisner D.P., Mahoney B.S., Petty C.N., Et al., Stuck twin syndrome: Outcome in 37 consecutive cases, Am J Obstet Gynecol, 169, pp. 991-995, (1993)

[9]

Trespidi L., Boschetto C., Caravelli E., Et al., Serial amniocenteses in the management of twin-twin transfusion syndrome: When is it valuable?, Fetal Diagn Ther, 12, pp. 15-20, (1997)

[10]

Saade G.R., Belfort M.A., Berry D.L., Et al., Amniotic septostomy for the treatment of twin oligohydramnios- polyhydramnios sequence, Fetal Diagn Ther, 13, pp. 86-93, (1998)

← 1 2 →